Understanding Your Stage 2 Ovarian Cancer

Receiving a cancer diagnosis is overwhelming, and it's natural to have many questions. We've prepared this overview to help you understand your stage 2 ovarian cancer diagnosis. This information is meant to be a starting point for a detailed discussion with your oncologist, who will tailor all treatments specifically to you.

Overview of Stage 2 Ovarian Cancer

Stage 2 ovarian cancer means the cancer is present in one or both ovaries and has spread to other pelvic tissues, such as the uterus, fallopian tubes, bladder or colon. It is still considered localized to the pelvic region and has not spread to distant sites outside the pelvis.

• Substages: Stage 2 is typically divided into:
• Stage 2A: Cancer has spread from the ovaries to the uterus or fallopian tubes (or both).
• Stage 2B: Cancer has spread to other pelvic tissues like the bladder, sigmoid colon or rectum.
• Significance: Because the cancer is still confined to the pelvis, it is often highly treatable with a good prognosis, particularly when compared to later-stage disease. Understanding the precise substage is crucial for determining the most effective treatment plan.

How Stage 2 Ovarian Cancer Is Diagnosed

The diagnosis process involves a combination of tests to confirm the cancer type, stage and overall health status.

• Physical Exam and Pelvic Exam: Your doctor will feel for masses or changes in the pelvic area.
• Imaging Tests: Transvaginal Ultrasound uses sound waves to create pictures of the ovaries and uterus. CT scans or MRI are used for detailed imaging to determine the extent of the cancer (staging) and check for spread to lymph nodes or other organs.
• Blood Tests: The CA-125 test measures a tumor marker that is often elevated in ovarian cancer. It’s frequently used to monitor response to treatment.
• Biopsy (or Surgery): The definitive diagnosis requires a tissue sample (biopsy), which is often obtained during the initial surgery (debulking surgery) where tissue is removed for staging and diagnosis by a pathologist.

“Tests for ovarian cancer are usually three different things: imaging, biopsy and blood tests. The imaging could be ultrasound, CT scan, MRI or a PET CT, and this is all just depending on level of suspicion as well as symptomatology. The biopsy usually takes place at the time of surgery,” Dr. Ryan Kahn, a gynecologic oncologist at Miami Cancer Institute, part of Baptist Health Cancer Care, said in an interview with CURE.

“This could also be done prior to surgery through interventional radiology or imaging in minimally invasive procedures to receive the biopsy. And the biopsy is key, because the tissue is necessary to make sure that this is ovarian cancer that we are treating and not metastatic disease from elsewhere,” he continued.

Treatment Options for Stage 2 Ovarian Cancer

The primary goal for stage 2 ovarian cancer is to remove as much of the cancer as possible (debulking) and eliminate any remaining cancer cells to prevent recurrence.

1. Surgery (Primary Treatment)

• Cytoreductive Surgery (Debulking): This is the most critical step. The surgeon aims to remove all visible cancer. This typically involves a total hysterectomy (removal of the uterus), bilateral salpingo-oophorectomy (removal of both ovaries and fallopian tubes), and removal of the omentum (a fatty tissue in the abdomen). Lymph nodes and other suspicious tissue are also sampled or removed.
• Optimal Debulking is achieved when the surgeon leaves behind no visible tumor, or tumors no larger than 1 cm.
• Timing: Surgery may be performed first (primary debulking) or after initial chemotherapy (neoadjuvant chemotherapy) if the tumor is too large or complex to remove safely at the outset.

2. Chemotherapy

Chemotherapy uses drugs to kill rapidly dividing cancer cells throughout the body.

• Standard Regimen: Typically involves a combination of a platinum-based drug (like carboplatin) and a taxane (like paclitaxel).
• Adjuvant Chemotherapy: Given after surgery to kill any remaining microscopic cancer cells. This is the most common approach for Stage 2 disease.
• Neoadjuvant Chemotherapy: Given before surgery to shrink the tumor, making the debulking surgery potentially more successful.

3. Targeted Therapy and Maintenance Treatment

• Targeted Therapy: Drugs that focus on specific features of cancer cells. PARP Inhibitors (e.g., Lynparza (olaparib)) are a common type used, especially for patients with a BRCA gene mutation. They are often given as maintenance therapy.
• Maintenance Therapy: Continued treatment after the initial treatment course is complete, intended to keep the cancer from returning for as long as possible.

Managing Side Effects of Ovarian Cancer Treatment

It's vital to discuss potential side effects with your oncologist, as managing them proactively significantly improves your quality of life during treatment.

• Surgery: Common effects include pain, fatigue, infection risk, temporary changes in bowel or bladder function, and early menopause (if ovaries are removed).
• Chemotherapy: The most common effects are nausea, vomiting, temporary hair loss, fatigue, neutropenia (low white blood cell count, increasing infection risk), anemia (low red blood cell count) and peripheral neuropathy (tingling or numbness in hands/feet). It is critical to report any signs of numbness or tingling immediately, as these side effects can sometimes be long-lasting and may require dose adjustment.
• PARP Inhibitors: These can cause nausea, vomiting, fatigue, anemia and muscle or joint pain.

Next Steps and Support for Living With Stage 2 Ovarian Cancer

Your stage 2 diagnosis is a significant challenge, but it is manageable. Treatment plans for ovarian cancer are constantly evolving, and your oncologist will create a plan based on the specific pathology of your tumor, your overall health and genetic test results.

Questions to Ask Your Oncologist About Stage 2 Ovarian Cancer:

1. Surgical Plan: What is the specific plan for my surgery, and will I receive neoadjuvant or adjuvant chemotherapy?
2. Genetic Testing: Should I undergo BRCA or other genetic testing to see if targeted (maintenance) therapy is an option?
3. Fertility: If preserving fertility is a concern for you, you must discuss this with your team before starting any treatment, as the standard surgery involves removing the ovaries and uterus.
4. Side Effect Management: How will we proactively manage side effects like nausea and neuropathy?

“If someone has been recently diagnosed with ovarian cancer, they need to speak to a fertility specialist immediately and see if freezing their eggs in advance is still feasible, or possibly after removing that ovary, maybe egg freezing can be performed with the other ovary,” Dr. Shahin Ghadir said on the topic of fertility in an interview with CURE. He is a board-certified in both obstetrics and gynecology, as well as reproductive endocrinology and infertility, at HRC Fertility of Beverly Hills.

Remember that you are not alone on this journey. Be open and honest with your medical team about your symptoms and concerns. Asking questions and staying informed is the best way to actively participate in your care.

Editor’s Note: This guide is designed to be a starting point. Your personal experience will be unique. By using this information as a foundation for your discussions, you can partner with your oncologist to make the best decisions for your health.

References

1. “An Expert Discusses Ovarian Cancer Basics, From Staging to Treatment,” by Alex Biese. CURE; Sept. 2, 2025. https://www.curetoday.com/view/an-expert-discusses-ovarian-cancer-basics-from-staging-to-treatment
2. “How Ovarian Cancer Treatment May Affect Fertility,” by Ryan Scott. CURE; Aug. 29, 2025. https://www.curetoday.com/view/how-ovarian-cancer-treatment-may-affect-fertility

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.